Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Aspergillus Endophthalmitis in a Large B-Cell Lymphoma Patient Publisher



Mousavifatemi K1 ; Adib NE2 ; Khosravi S1 ; Dehdashti M1 ; Biglari M3, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Hematologist and Medical Oncologist Hematology, Oncology, Stem Cell Transplantation Research Center, Research Institute for Oncology Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Ophtalmology, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Fellowship of Hematology and Medical Oncology Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Shariati Hospital, N. Kargar St., Tehran, 14114-13137, Iran

Source: Journal of Applied Hematology Published:2021


Abstract

To highlight the graveness of invasive Aspergillus infections that could end in serious complications in immunocompromised patients, we are going to report a rare case of bilateral Aspergillus endophthalmitis in a lymphoma patient. We present a case in an academic referring hospital. The patient was an immunocompromised patient with diffuse large B-cell lymphoma complicated with vision loss due to Aspergillus infection diagnosed with B-mode ultrasound and culture and followed by treatment with vitrectomy and intravitreous amphotericin. The patient was followed for 9 months, culminating in visual acuity of 4/100 and 1/100 in her left and right eye, respectively. Despite appropriate diagnosis and treatment, invasive Aspergillus infection may still have a poor prognosis. © 2022 Journal of Applied Hematology.